AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ventana Biotech, Inc.

$0.05 +$0.01 (+32.79%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.05
Day Range
$0.03$0.05
Year Range
$0.02$0.08
Market Cap
134.91K
AVG Volume
311
Trailing/Forward PE
30.62/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
020K40K60K20232024
VNTA Revenue (USD) by year
PeriodRevenue (USD)
202441.11K
202329.09K
Net Income (USD)
010K20K30K20232024
VNTA Net Income (USD) by year
PeriodNet Income (USD)
202420.34K
202316.6K
Operating Income (USD)
010K20K30K20232024
VNTA Operating Income (USD) by year
PeriodOperating Income (USD)
202421.24K
202317.37K
EBITDA (USD)
010K20K30K20232024
VNTA EBITDA (USD) by year
PeriodEBITDA (USD)
202421.24K
202317.37K
EPS (USD)
0000020232024
VNTA EPS (USD) by year
PeriodEPS (USD)
20240
20230
Expenses (USD)
05K10K15K20K20232024
VNTA Expenses (USD) by year
PeriodExpenses (USD)
202419.87K
202313.1K
Cash & Debt (USD)
050K100K150KCashShort Term Debt20232024
VNTA Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202461.09K
202334.15K
Debt ratios
00.20.40.620232024
VNTA Debt ratios by year
PeriodDebt ratios
20240.53
20230.32
Margins
0%20%40%60%20232024
VNTA Margins by year
PeriodMargins
202449.47%
202357.07%
Return on Capital
-40%-30%-20%-10%0%20232024
VNTA Return on Capital by year
PeriodReturn on Capital
2024-37.71%
2023-22.35%
Shares Outstanding
020M40M60M20232024
VNTA Shares Outstanding by year
PeriodShares Outstanding
202453.78M
202353.78M
Book Value Per Share (USD)
-0-0-0020232024
VNTA Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0
2023-0
Total Assets (USD)
020K40K60K80K20232024
VNTA Total Assets (USD) by year
PeriodTotal Assets (USD)
202461.09K
202334.15K
PE Ratio
050010001500med 39.98Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VNTA PE Ratio by year
PeriodPE Ratio
Sep 2630.59
Sep 2630.59
Aug 2630.59
Aug 2630.59
Aug 2630.59
Aug 2620.6
Jul 2620.6
Jul 2620.6
Jul 2620.6
Jul 2620.6
Jul 2639.34
Jun 2639.34
Jun 2639.34
Jun 2636.84
Jun 2623.1
May 2623.1
May 2623.1
May 2623.1
May 2623.1
May 2625.6
Apr 2625.6
Apr 2625.6
Apr 2625.6
Apr 2625.04
Mar 2639.98
Mar 2639.98
Mar 2639.98
Mar 2639.98
Feb 2639.98
Feb 2639.98
Feb 2639.98
Feb 2639.98
Jan 2639.98
Jan 2640.52
Jan 2639.98
Jan 2639.87
Jan 2639.87
Dec 25637.62
Dec 25972.54
Dec 25972.54
Dec 25972.54
Nov 251034.54
Nov 25731.51
Nov 25766.74
Nov 25766.74
Oct 25768.34
Oct 25768.34
Oct 251259.31
Oct 25513.29
Oct 25345.91
Sep 2557.39
Sep 2558.18
Sep 2557.39
Sep 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2556.86
Jul 2556.86
Jul 2556.86
Jul 2563.73
Jul 2563.73
Jun 2565.17
Jun 2565.17
Jun 2565.17
Jun 2565.11
May 2565.11
May 2565.11
May 2581.36
May 2548.94
May 2548.94
Apr 2547.32
Apr 2567.57
Apr 2567.57
Apr 2529.74
Mar 25158.27
Mar 2512.39
Mar 2512.39
Mar 2512.39
Feb 2510.91
Feb 2510.78
Feb 2510.78
Feb 259.56
Jan 258.22
Jan 250.67
Jan 250.67
Jan 2510.78
Jan 2510.78
Dec 2416.42
Dec 2459.12
Dec 2459.12
Dec 24123.16
Nov 2416.42
Nov 24328.44
Nov 24328.44
Nov 24328.44
Nov 24862.14
Oct 24862.14
Oct 24862.14
Price to Sales
0200400600med 29.06Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VNTA Price to Sales by year
PeriodPrice to Sales
Sep 2623
Sep 2623
Aug 2623
Aug 2623
Aug 2623
Aug 2615.49
Jul 2615.49
Jul 2615.49
Jul 2615.49
Jul 2615.49
Jul 2629.57
Jun 2629.57
Jun 2629.57
Jun 2627.7
Jun 2617.37
May 2617.37
May 2617.37
May 2617.37
May 2617.37
May 2619.25
Apr 2619.25
Apr 2619.25
Apr 2619.25
Apr 2618.82
Mar 2629.41
Mar 2629.41
Mar 2629.41
Mar 2629.41
Feb 2629.41
Feb 2629.41
Feb 2629.41
Feb 2629.41
Jan 2629.41
Jan 2629.81
Jan 2629.41
Jan 2629.33
Jan 2629.33
Dec 25100.53
Dec 25153.33
Dec 25153.33
Dec 25153.33
Nov 25163.11
Nov 25115.33
Nov 25120.89
Nov 25120.89
Oct 25121.14
Oct 25121.14
Oct 25198.55
Oct 2580.93
Oct 2554.54
Sep 2528.39
Sep 2528.78
Sep 2528.39
Sep 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.13
Jul 2528.13
Jul 2528.13
Jul 2531.53
Jul 2531.53
Jun 2531.34
Jun 2531.34
Jun 2531.34
Jun 2531.31
May 2531.31
May 2531.31
May 2539.13
May 2523.54
May 2523.54
Apr 2522.76
Apr 2532.49
Apr 2532.49
Apr 2514.3
Mar 25108.9
Mar 258.53
Mar 258.53
Mar 258.53
Feb 257.51
Feb 257.41
Feb 257.41
Feb 256.58
Jan 255.65
Jan 250.46
Jan 250.46
Jan 257.41
Jan 257.41
Dec 2410.85
Dec 2439.06
Dec 2439.06
Dec 2481.38
Nov 2410.85
Nov 24217.02
Nov 24217.02
Nov 24217.02
Nov 24569.68
Oct 24569.68
Oct 24569.68
EV/EBITDA
01000200030004000med 227.94Apr 24Jun 24Aug 24Apr 25Jun 25Aug 25Sep 25
VNTA EV/EBITDA by year
PeriodEV/EBITDA
Sep 2557.39
Sep 2558.15
Sep 2557.39
Sep 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2556.88
Jul 2556.88
Jul 2556.88
Jul 2563.46
Jul 2563.46
Jun 2564.62
Jun 2564.62
Jun 2564.62
Jun 2564.57
May 2564.57
May 2564.57
May 2580.11
May 2549.1
May 2549.1
Apr 2547.55
Apr 2566.92
Apr 2566.92
Apr 2530.74
Sep 24375.76
Sep 242605.38
Sep 242605.38
Sep 242964.59
Aug 243224.71
Aug 242853.11
Aug 243038.91
Aug 243038.91
Aug 242853.11
Jul 242853.11
Jul 242853.11
Jul 242853.11
Jul 243100.85
Jun 242916.57
Jun 242916.57
Jun 243732.13
Jun 243732.13
May 243732.13
May 242683.55
May 242683.55
May 242683.55
May 243499.11
Apr 243499.11
Apr 243499.11
Apr 243033.08
Apr 243033.08
Ventana Biotech, Inc.
VNTA
Stockpicker

Video analysis: VNTA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VNTA

Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives

accessnewswire.com · 27 Aug 2026

Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives

VANCOUVER, BC / ACCESS Newswire / August 27, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that it has engaged the services of Independent Trading Group (ITG) Inc. ("ITG") to provide market-making services in accordance with Canadian Securities Exchange ("CSE") policies, effective August 27, 2026. The engagement of ITG forms part of the Company's broader strategic capital markets initiatives, aimed at enhancing trading liquidity, supporting orderly market conditions, and improving overall market quality for the Company's common shares.

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET

accessnewswire.com · 21 Jul 2026

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET

VANCOUVER, BC / ACCESS Newswire / July 21, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that, further to its news release dated July 6, 2026, regarding the Company's participation in Maxim Group LLC's ("Maxim Group") "Health, Wellness & Longevity" virtual conference, the scheduled time of the fireside chat featuring Marcello Leone, Chief Executive Officer of Vanta, has been updated. The fireside chat will now take place on Wednesday, July 22, 2026, at 12:00 p.m.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.